280 related articles for article (PubMed ID: 36496973)
21. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis.
Jeny F; Bernaudin JF; Valeyre D; Kambouchner M; Pretolani M; Nunes H; Planès C; Besnard V
Front Immunol; 2021; 12():719009. PubMed ID: 34456926
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia and TNF-α Synergistically Induce Expression of IL-6 and IL-8 in Human Fibroblast-like Synoviocytes via Enhancing TAK1/NF-κB/HIF-1α Signaling.
Wang G; Wang J; Li X; Wu Q; Yao R; Luo X
Inflammation; 2023 Jun; 46(3):912-924. PubMed ID: 36607540
[TBL] [Abstract][Full Text] [Related]
24. Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.
Winner M; Koong AC; Rendon BE; Zundel W; Mitchell RA
Cancer Res; 2007 Jan; 67(1):186-93. PubMed ID: 17210698
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow.
Lévesque JP; Winkler IG; Hendy J; Williams B; Helwani F; Barbier V; Nowlan B; Nilsson SK
Stem Cells; 2007 Aug; 25(8):1954-65. PubMed ID: 17478585
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-inducible factor-1α inhibition augments efficacy of programmed cell death 1 antibody in murine prostatic cancer models.
Shen Z; Pei Q; Zhang H; Yang C; Cui H; Li B; Liu J; Bo Z; Wei F; Zhang M; Liu C
Anticancer Drugs; 2022 Jul; 33(6):587-594. PubMed ID: 35324523
[TBL] [Abstract][Full Text] [Related]
27. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.
Riddell JR; Maier P; Sass SN; Moser MT; Foster BA; Gollnick SO
PLoS One; 2012; 7(11):e50394. PubMed ID: 23185615
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
[TBL] [Abstract][Full Text] [Related]
29. HIF-1α (Hypoxia-Inducible Factor-1α) Promotes Macrophage Necroptosis by Regulating miR-210 and miR-383.
Karshovska E; Wei Y; Subramanian P; Mohibullah R; Geißler C; Baatsch I; Popal A; Corbalán Campos J; Exner N; Schober A
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):583-596. PubMed ID: 31996026
[TBL] [Abstract][Full Text] [Related]
30. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia Potentiates Palmitate-induced Pro-inflammatory Activation of Primary Human Macrophages.
Snodgrass RG; Boß M; Zezina E; Weigert A; Dehne N; Fleming I; Brüne B; Namgaladze D
J Biol Chem; 2016 Jan; 291(1):413-24. PubMed ID: 26578520
[TBL] [Abstract][Full Text] [Related]
32. Systems pharmacology reveals the mechanism of Astragaloside IV in improving immune activity on cyclophosphamide-induced immunosuppressed mice.
Yao J; Liu J; He Y; Liu L; Xu Z; Lin X; Liu N; Kai G
J Ethnopharmacol; 2023 Sep; 313():116533. PubMed ID: 37100262
[TBL] [Abstract][Full Text] [Related]
33. HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation.
Li ZL; Lv LL; Tang TT; Wang B; Feng Y; Zhou LT; Cao JY; Tang RN; Wu M; Liu H; Crowley SD; Liu BC
Kidney Int; 2019 Feb; 95(2):388-404. PubMed ID: 30551896
[TBL] [Abstract][Full Text] [Related]
34. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1.
Knowles HJ; Mole DR; Ratcliffe PJ; Harris AL
Cancer Res; 2006 Mar; 66(5):2600-7. PubMed ID: 16510578
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1alpha-dependent manner.
Anand RJ; Gribar SC; Li J; Kohler JW; Branca MF; Dubowski T; Sodhi CP; Hackam DJ
J Leukoc Biol; 2007 Nov; 82(5):1257-65. PubMed ID: 17675562
[TBL] [Abstract][Full Text] [Related]
36. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
38. Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis.
Jones JD; Sinder BP; Paige D; Soki FN; Koh AJ; Thiele S; Shiozawa Y; Hofbauer LC; Daignault S; Roca H; McCauley LK
Neoplasia; 2019 Feb; 21(2):172-184. PubMed ID: 30591422
[TBL] [Abstract][Full Text] [Related]
39. HIF-1α facilitates osteocyte-mediated osteoclastogenesis by activating JAK2/STAT3 pathway in vitro.
Zhu J; Tang Y; Wu Q; Ji YC; Feng ZF; Kang FW
J Cell Physiol; 2019 Nov; 234(11):21182-21192. PubMed ID: 31032948
[TBL] [Abstract][Full Text] [Related]
40. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
Seo K; Seo S; Ki SH; Shin SM
Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]